Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review

Abstract

Nanomedicine offers considerable opportunities to improve drugability and reduce toxicity for tumour therapy. However, the application of nanomedicine has achieved little success in clinical trials due to multiple physiological barriers to drug delivery. Circulating cells are expected to improve the physical distribution of drugs and enhance the therapeutic effect by overcoming various biological barriers in collaboration with nano-drug delivery systems owing to excellent biocompatibility, low immunogenicity and a long-circulation time and strong binding specificity. Nonetheless, we have noticed some limitations in implementing tthe strategy. In this article, we intend to introduce the latest progress in research and application of circulating cell-mediated nano-drug delivery systems, describe the main cell-related drug delivery modes, sum up the relevant points of the transport systems in the process of loading, transport and release, and lastly discuss the advantages, challenges and future development trends in cell-mediated nano-drug delivery.

Keywords:

• Circulating cells
• nanoparticles
• drug delivery system
• cancer

Author contributions

Jianming Chen: Conceptualisation, Methodology; Wuhao Wei, Yuansheng Zhang, Zhizhe Li: Data curation,Writing-Original draft preparation; Xin Wu: Reviewing and Editing; Wei Fan:Supervision,Validation.